IP Library Granted Patent US 9,062,295
Granted Patent B2
US 9,062,295 · App. 13/669,776 · Granted Jun 23, 2015

Recombinant polypeptides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,062,295
App. No.
13/669,776
Granted
Jun 23, 2015
Kind
B2
Abstract

In one aspect, the invention is directed to polypeptides having an amylase activity, polynucleotides encoding the polypeptides, and methods for making and using these polynucleotides and polypeptides. In one aspect, the polypeptides of the invention can be used as amylases, for example, alpha amylases, to catalyze the hydrolysis of starch into sugars.

Claims (12)

1. A recombinant polypeptide comprising an amino acid fragment of the amino acid sequence as set forth in SEQ ID NO:2, wherein the amino acid fragment length is greater than 50 and less than 435 consecutive amino acid residues of the amino acid sequence as set forth in SEQ ID NO: 2.

2. The recombinant polypeptide of claim 1 , wherein the amino acid fragment length is greater than 75 and less than 435 consecutive amino acid residues of the amino acid sequence as set forth in SEQ ID NO: 2.

3. The recombinant polypeptide of claim 1 , wherein the amino acid fragment length is greater than 100 and less than 435 consecutive amino acid residues of the amino acid sequence as set forth in SEQ ID NO: 2.

4. The recombinant polypeptide of claim 1 , wherein the amino acid fragment length is greater than 150 and less than 435 consecutive amino acid residues of the amino acid sequence as set forth in SEQ ID NO: 2.

5. The recombinant polypeptide of claim 1 , wherein the amino acid fragment length is greater than 200 and less than 435 consecutive residues of the amino acid sequence as set forth in SEQ ID NO: 2.

6. The recombinant polypeptide of claim 1 , wherein the amino acid fragment length is greater than 250 and less than 435 consecutive residues of the amino acid sequence as set forth in SEQ ID NO: 2.

7. The recombinant polypeptide of claim 1 , wherein said polypeptide comprises 350 the amino acid fragment length is greater than 300 and less than 435 consecutive residues of the polypeptide of amino acid sequence as set forth in SEQ ID NO: 2.

8. The recombinant polypeptide of claim 1 , wherein said polypeptide comprises 350 the amino acid fragment length is greater than 350 and less than 435 consecutive residues of the polypeptide of amino acid sequence as set forth in SEQ ID NO: 2.

9. A hybrid polypeptide comprising the recombinant polypeptide of claim 1 , linked to a second polypeptide.

10. The hybrid polypeptide of claim 9 , wherein the second polypeptide is an alpha-amylase.

11. The hybrid polypeptide of claim 10 , wherein the alpha-amylase is a bacillus alpha-amylase.

12. A hybrid polypeptide comprising an enzymatically active amino acid fragment of the amino acid sequence as set forth in SEQ ID NO: 2, linked to an alpha amylase from Bacillus .

Assignments (4)
CHANGE OF NAME Recorded May 19, 2015
From: VERENIUM CORPORATION
To: BASF ENZYMES LLC
Reel/Frame 035727/0867 →
RELEASE OF SECURITY INTEREST Recorded Jan 9, 2014
From: ATHYRIUM OPPORTUNITIES FUND (A) LP
To: VERENIUM CORPORATION
Reel/Frame 031956/0016 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2013
From: CALLEN, WALTER; RICHARDSON, TOBY; FREY, GERHARD; MILLER, CARL A.; KAZAOKA, MARTIN; MATHUR, ERIC J.; SHORT, JAY M.; DIVERSA CORPORATION
To: VERENIUM CORPORATION
Reel/Frame 030634/0765 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Dec 11, 2012
From: VERENIUM CORPORATION
To: ATHYRIUM OPPORTUNITIES FUND (A) LP
Reel/Frame 029444/0119 →